541 related articles for article (PubMed ID: 23114585)
1. New treatment strategies in large-vessel vasculitis.
Unizony S; Stone JH; Stone JR
Curr Opin Rheumatol; 2013 Jan; 25(1):3-9. PubMed ID: 23114585
[TBL] [Abstract][Full Text] [Related]
2. Biologic treatment of large-vessel vasculitides.
Schäfer VS; Zwerina J
Curr Opin Rheumatol; 2012 Jan; 24(1):31-7. PubMed ID: 22089099
[TBL] [Abstract][Full Text] [Related]
3. Tocilizumab for the treatment of large-vessel vasculitis (giant cell arteritis, Takayasu arteritis) and polymyalgia rheumatica.
Unizony S; Arias-Urdaneta L; Miloslavsky E; Arvikar S; Khosroshahi A; Keroack B; Stone JR; Stone JH
Arthritis Care Res (Hoboken); 2012 Nov; 64(11):1720-9. PubMed ID: 22674883
[TBL] [Abstract][Full Text] [Related]
4. Vasculitis therapy refines vasculitis mechanistic classification.
Torp CK; Brüner M; Keller KK; Brouwer E; Hauge EM; McGonagle D; Kragstrup TW
Autoimmun Rev; 2021 Jun; 20(6):102829. PubMed ID: 33872767
[TBL] [Abstract][Full Text] [Related]
5. Biotherapies in large vessel vasculitis.
Ferfar Y; Mirault T; Desbois AC; Comarmond C; Messas E; Savey L; Domont F; Cacoub P; Saadoun D
Autoimmun Rev; 2016 Jun; 15(6):544-51. PubMed ID: 26883459
[TBL] [Abstract][Full Text] [Related]
6. Tocilizumab: a novel therapy for patients with large-vessel vasculitis.
Salvarani C; Magnani L; Catanoso M; Pipitone N; Versari A; Dardani L; Pulsatelli L; Meliconi R; Boiardi L
Rheumatology (Oxford); 2012 Jan; 51(1):151-6. PubMed ID: 22075063
[TBL] [Abstract][Full Text] [Related]
7. Treatment of Giant Cell Arteritis and Takayasu Arteritis-Current and Future.
Hellmich B; Águeda AF; Monti S; Luqmani R
Curr Rheumatol Rep; 2020 Oct; 22(12):84. PubMed ID: 33044642
[TBL] [Abstract][Full Text] [Related]
8. Refractory Takayasu arteritis successfully treated with rituximab: case-based review.
Mutoh T; Ishii T; Shirai T; Akita K; Kamogawa Y; Fujita Y; Sato H; Shirota Y; Fujii H; Harigae H
Rheumatol Int; 2019 Nov; 39(11):1989-1994. PubMed ID: 31388749
[TBL] [Abstract][Full Text] [Related]
9. Two Takayasu arteritis patients successfully treated with rituximab.
Caltran E; Di Colo G; Ghigliotti G; Capecchi R; Catarsi E; Puxeddu I; Migliorini P; Tavoni A
Clin Rheumatol; 2014 Aug; 33(8):1183-4. PubMed ID: 24478126
[TBL] [Abstract][Full Text] [Related]
10. Management of large-vessel vasculitis.
Salvarani C; Hatemi G
Curr Opin Rheumatol; 2019 Jan; 31(1):25-31. PubMed ID: 30461542
[TBL] [Abstract][Full Text] [Related]
11. Therapeutic update in large vessel vasculitides.
Pérez-Esteban S; González-Gay MA; Castañeda S
Rev Clin Esp (Barc); 2013 Oct; 213(7):338-46. PubMed ID: 23683962
[TBL] [Abstract][Full Text] [Related]
12. 2018 Update of the EULAR recommendations for the management of large vessel vasculitis.
Hellmich B; Agueda A; Monti S; Buttgereit F; de Boysson H; Brouwer E; Cassie R; Cid MC; Dasgupta B; Dejaco C; Hatemi G; Hollinger N; Mahr A; Mollan SP; Mukhtyar C; Ponte C; Salvarani C; Sivakumar R; Tian X; Tomasson G; Turesson C; Schmidt W; Villiger PM; Watts R; Young C; Luqmani RA
Ann Rheum Dis; 2020 Jan; 79(1):19-30. PubMed ID: 31270110
[TBL] [Abstract][Full Text] [Related]
13. Rescue treatment with tocilizumab for Takayasu arteritis resistant to TNF-α blockers.
Salvarani C; Magnani L; Catanoso MG; Pipitone N; Versari A; Dardani L; Pulsatelli L; Meliconi R; Boiardi L
Clin Exp Rheumatol; 2012; 30(1 Suppl 70):S90-3. PubMed ID: 22410150
[TBL] [Abstract][Full Text] [Related]
14. Pathophysiology of large vessel vasculitis and utility of interleukin-6 inhibition therapy.
Yoshifuji H
Mod Rheumatol; 2019 Mar; 29(2):287-293. PubMed ID: 30427262
[TBL] [Abstract][Full Text] [Related]
15. Reducing the Toxicity of Long-Term Glucocorticoid Treatment in Large Vessel Vasculitis.
Palmowski A; Buttgereit F
Curr Rheumatol Rep; 2020 Oct; 22(12):85. PubMed ID: 33047263
[TBL] [Abstract][Full Text] [Related]
16. Tocilizumab for the treatment of giant cell arteritis.
Schirmer M; Muratore F; Salvarani C
Expert Rev Clin Immunol; 2018 May; 14(5):339-349. PubMed ID: 29676602
[TBL] [Abstract][Full Text] [Related]
17. The pathology of large-vessel vasculitides.
Miller DV; Maleszewski JJ
Clin Exp Rheumatol; 2011; 29(1 Suppl 64):S92-8. PubMed ID: 21586202
[TBL] [Abstract][Full Text] [Related]
18. Tocilizumab: a new therapy for large vessel vasculitis.
Al-Homood IA
Clin Exp Med; 2014 Nov; 14(4):355-60. PubMed ID: 23949338
[TBL] [Abstract][Full Text] [Related]
19. Tocilizumab in the treatment of giant cell arteritis.
Leuchten N; Aringer M
Immunotherapy; 2018 Mar; 10(6):465-472. PubMed ID: 29504436
[TBL] [Abstract][Full Text] [Related]
20. Biological treatments in giant cell arteritis & Takayasu arteritis.
Samson M; Espígol-Frigolé G; Terrades-García N; Prieto-González S; Corbera-Bellalta M; Alba-Rovira R; Hernández-Rodríguez J; Audia S; Bonnotte B; Cid MC
Eur J Intern Med; 2018 Apr; 50():12-19. PubMed ID: 29146018
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
